CUBN and agammaglobulinemia: Immunoglobulin (Ig) replacement therapy (IgRT) consists of the administration of low-doses human polyclonal Igs for the treatment of primary and secondary hypogammaglobulinemia, characterized by low serum levels of immunoglobulins that is associated with recurrent infections and immune dysfunction.